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of Koch and continued by gradually pulling the catheterIntroduction
Catheter ablation of atrioventricular nodal reentrant tachy-
cardia (AVNRT) and atrioventricular reentrant tachycardia is
an established procedure with a high success rate, but
procedure-related complications are not rare.1 One of the
feared complications is coronary injury, the frequency of
which is estimated to ber1%. We have recently shown that
the risk of coronary artery injury is especially high when
ablating in the coronary sinus (CS) branches, such as the
middle cardiac vein (MCV), and the risk correlates inversely
with the distance from the ideal ablation site in the CS to the
coronary artery. If this distance is o2 mm, the risk of
coronary artery injury is as high as 50%.2 Understanding the
relationship between coronary arteries and the CS is essential
to avoid this complication. We describe 2 cases in which
ablation in a presumed safe area resulted in coronary injury.Case reports
Case 1
A 17-year-old white male presented to our institution with
severely symptomatic tachycardia refractory to medical ther-
apy. During electrophysiology study, AVNRTwas induced and
targeted for ablation. A magnetic navigation catheter (Stereo-
taxis, St. Louis, MO) in an SR-0 sheath was used to create a
CARTO map (Biosense Webster; Johnson and Johnson, New
Brunswick, NJ) and to perform the ablation. A CS venogram
was not performed.
In all, 3 separate radiofrequency (RF) applications at 25
W were delivered. The lesions started at the inferior triangleKEYWORDS Atrioventricular nodal reentrant tachycardia; Atrioventricular
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Junctional beats were seen during the RF applications closer
to the CS ostium. During the third RF application, the
ablation catheter suddenly moved inferiorly, possibly into
the MCV. RF energy was stopped soon after catheter
movement was noted. As seen in his echocardiogram
(ECG), ST elevation developed in the inferior leads (aVF,
III) shortly after this RF application (Figure 1A). Reduction
of his clinical arrhythmia was not attempted secondary to the
presence of ST elevation. Of note, during ablation, only leads
I, II, and V1 were monitored at a paper speed of 200 mm/s
and ST elevation was not appreciated during RF application.
The patient was immediately transferred to the cardiac
catheterization laboratory. Access was obtained via the radial
artery. The right coronary artery (RCA) was angiographically
dominant, and the RCA and right posterior descending artery
were both normal. At the ostium of the right posterior-lateral,
there was a complete occlusion, as shown in Figure 1B.
Aspiration thrombectomy did not retrieve signiﬁcant throm-
bus, and a 2  18-mm bare metal stent was deployed. The
ﬁnal angiographic result was excellent, with TIMI-3 ﬂow, as
seen in Figure 1C. A transthoracic echocardiogram performed
the day after ablation revealed normal systolic function and
mild hypokinesis of the inferior myocardium. The patient was
discharged on acetylsalicylic acid for life and clopidogrel for
30 days. At 14 months of follow-up, he has had no clinical
tachycardia recurrence or chest discomfort.Case 2
A 39-year-old white female with preexcitation presented to
our institution after 2 previous unsuccessful ablations. A
CS angiogram, performed at the start of our case, did not
reveal any abnormalities. Through mapping of the right
atrium during ventricular pacing, the accessory pathway
(AP) was identiﬁed near the roof of the CS, approximately
1.5 cm from the ostium, which is generally thought not to
be a high-risk area for coronary artery injury. We monitored
antegrade preexcitation during RF application, and ablation
at this site eliminated conduction in 1 second. Considering
the patient’s history of 2 previous failed ablations and thepen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.04.008
KEY TEACHING POINTS
 Variations in coronary artery dominance and the
relationship to the coronary sinus can lead to
unexpected injury to a coronary artery during
coronary sinus ablation. Maintaining alertness during
coronary sinus radiofrequency application is critical.
 Monitoring the relevant surface
electrocardiographic leads during ablation at a
sweep speed of 25 mm/s in addition to monitoring
of the 12-lead electrocardiogram immediately after
ablation are 2 simple measures that can prevent
dramatic complications.
 Performing a coronary angiogram on every patient
undergoing coronary sinus ablation is excessive,
tipping the risk–beneﬁt ratio the other direction.
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Figure 1 A: Case 1 postablation electrocardiogram showing inferior ST elev
posterolateral branch, with an arrow marking the occlusion and location of ablatiodistal and proximal to the original A fourth application was
applied to the ventricular end of the AP, at the level of mid
CS ostium. Shortly after the third ablation, ST elevation
was noted in the inferior leads (Figure 2A), and a coronary
angiogram was performed via the radial artery. Of note,
during ablation, only leads I, II, and V1 were monitored at a
paper speed of 200 mm/s, and ST elevation was not
appreciated.
An angiogram showed the RCA, left main coronary
artery, and left anterior descending artery to be normal.
The left circumﬂex was dominant. At the ostium of the
second obtuse marginal, there was a 100% occlusion, as
shown in Figure 2B. Because aspiration thrombectomy
was nonproductive, a balloon and a bare metal stent
resulted in TIMI-3 ﬂow, as shown in Figure 2C. A
transthoracic echocardiogram revealed normal systolic
function with hypokinesis of the basal inferolateral and
inferior myocardium. The patient was discharged on
acetylsalicylic acid for life and ticagrelor for 1 year. At
15 months of follow-up, she has had no tachycardia
recurrence or chest pain.ation. B: Angiogram of right coronary artery before intervention of right
n. C: Angiogram after intervention.
AB C
Figure 2 A: Case 2 postablation electrocardiogram showing inferior ST elevation. B: Angiogram of left circumﬂex dominant coronary system, before
intervention, with an arrow marking the occlusion. C: Angiogram after intervention to the second obtuse marginal.
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Understanding the relationship of the coronary arteries to the
CS is critical during ablation. The left circumﬂex artery is
located on the epicardial surface of the atrioventricular
groove, near the CS. The CS is usually situated more atrial
to the atrioventricular groove, as shown in Figure 3, with
only 16% of cases in the “normal” atrioventricular (AV)
groove position. Figures 3A and 3B show this relationship
with a venogram and arteriogram in the right anterior oblique
projection. Figures 3C and 3D show this in the left anterior
oblique projection. The more atrial CS path varies: 1–3 mm
above the AV groove is seen in 12% of patients, a moderate
elevation (4–7 mm) in 50%, and an extreme elevation (8–15
mm) in 22%. As the left cardiac chambers and mitral annulus
dilate, the CS shifts toward the ventricular part of the mitral
valve annulus.3
Two previous studies searched for coronary artery injury
and found the incidence of ablation-related coronary injury
to be 1%.4,5 Retrospective and prospective registries have
reported coronary artery injury from ablation as low as
0.06%–0.1% in adults and 0.03% in children.6–8 Theunderlying mechanism for injury is not completely under-
stood. Transient thermal irritability resulting in coronary
spasm appears to be the primary mechanism, and this
stenosis can be relieved with intracoronary glycerine trini-
trate in 100% of patients, as described in a recent study.9
However, an additional inﬂammatory component may exist.
As noted in reports of animal experiments, the inﬂammatory
component may result in delayed medial necrosis and intimal
hyperplasia causing late stenosis.10 Unfortunately, the risk
factors that predispose patients to coronary artery injury are
not completely deﬁned. One proposed hypothesis is that
vesselso3 mm in diameter do not have the protection of the
heat-sink effect, making them more vulnerable to RF heat
and therefore injury. Certain procedural situations, by virtue
of the targeted site for ablation, may also increase this risk.
These scenarios include linear ablation within the CS,
epicardial posteroseptal APs, and ablation of AVNRT.
Linear ablation within the CS to create an LA isthmus line
may lead to circumﬂex artery injury. Longstanding persistent
atrial ﬁbrillation with perimitral ﬂutter is a common form
of LA macroreentry. Procedural success usually requires
RAO: venogram RAO: arteriogram
LAO: venogram LAO: arteriogram
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Figure 3 A and B: Right anterior oblique (RAO) 301 views of a venogram and arteriogram demonstrating the relationship of the coronary sinus/middle
cardiac vein (broken line), left circumﬂex artery (solid double line), and posterior descending artery (dots). The arrow shows the atrial aspect of the CS.C and D:
The same procedures viewed at left anterior oblique (LAO) 501.
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tachycardia or create an LA isthmus block, often necessitat-
ing extension ablation. Wong et al9 found that 28% of their
patients had circumﬂex artery angiographic changes post
ablation, when compared with preprocedure coronary angio-
grams. Of note, 33% of these patients had a signiﬁcant
response to intracoronary glycerine trinitrate. Makimoto
et al11 reported a case of delayed incessant ventricular
tachycardia 440 hours after the creation of an LA isthmus
line in the coronary venous system.
Coronary injury may result from ablation of epicardial
posteroseptal APs that used part of the CS muscle for
conduction. The ablation target, where the ventricular end
of the epicardial AP is located, is often within a tributary of
the CS, the MCV, or the neck of a CS diverticulum. Stavrakis
et al2 reviewed results of 240 patients with such pathways
and their preablation coronary angiograms. They found an
inverse correlation between the risk of coronary artery injury
and the distance from the ablation site, with a 50% risk if the
target was within 2 mm of the artery.
Ablation of AVNRT can also lead to coronary artery
injury. The atrioventricular node (AVN) artery is the primary
blood supply to the AVN as well as the His bundle. Theposterior descending and posterolateral left ventricular
branches also supply the inferior aspect of the interventric-
ular septum. Arterial supply varies with dominance of the
coronary circulation. In approximately 85% of patients in
whom the circulation is right dominant, the AVN artery is
supplied by a branch of the RCA. In patients who have left-
dominant circulation, the AVN artery originates from the left
circumﬂex artery.12 The AVN artery usually ends as single
vessel, with the remainder being shaped like a fork or as a
double-stranded vessel. Lin et al13 studied the risk of AV
block during slow pathway ablation for AVNRT using
coronary angiography either before or after ablation. Irre-
spective of other common electrophysiology signals, they
found that an ablation distance ofo2 mm to the distal end of
the AV nodal artery almost always caused suprahisian block.
This case series exposes the inherent dangers to the
coronary circulation when RF energy is delivered within or
near the CS, especially when the targeted area is thought to be
safe. Multiple ablation procedures may increase the risk of
damage to coronary arteries, but this relationship has not been
studied speciﬁcally. In our institute, coronary angiography is
performed in patients when the ablation target may be near the
coronary artery, especially if it is located in the MCV or at the
319Garabelli et al Coronary Injury from Coronary Sinus Ablationﬂoor of the proximal CS. However, coronary angiograms are
not performed on every patient when the ablation target is
located at the CS ostium, such as with AVNRT.
Performing preablation angiograms on every patient in such
cases seems excessive. Diagnostic cardiac catheterization is
safe, with a complication rate from death, myocardial infarc-
tion, or major embolization that is well below 1%.14 In centers
that perform high-volume radial access, vascular complications
are reduced even further.15 Although there are no data
speciﬁcally addressing preablation angiograms, or even cardiac
computed tomography scans, when ablation within the CS is
contemplated, speciﬁc pros (noninvasive, well-deﬁned anat-
omy) and cons (contrast load, increased radiation exposure) of
each approach will need to be evaluated by the physician for
each patient. Regardless, an understanding of coronary artery
variances in relation to the CS is essential, especially when
ablation within the coronary sinus may be required.
Conclusion
Keeping a high degree of suspicion for coronary artery injury
with CS RF application is highly recommended. Checking
relevant ECG leads for ST changes at a sweep speed of 25–
100 mm/s during an ablation may not be feasible in all
patients, such as when AV conduction is being monitored.
However, checking a 12-lead ECG immediately after abla-
tion is a critical step that can diagnose ST changes and
possibly prevent dramatic complications. Performing imag-
ing of the coronary circulation on every patient undergoing
CS ablation, whether with a cardiac computed tomography
scan or with a diagnostic catheterization, may be unneces-
sary and should be individualized for each case.
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